FDA authorized updated Novavax COVID-19 vaccine formulated to better protect against currently circulating variant
On Oct. 3, 2023, the U.S. Food and Drug Administration (FDA) amended the emergency use authorization (EUA) of…
Biotechnology | CDC | COVID-19 | FDA | Infectious Disease | Life Science News | Vaccine
Novavax 2023-2024 COVID-19 Vaccine Authorized and Recommended for Use in the U.S.
On Oct. 3, 2023, Novavax announced that it’s COVID-19 Vaccine, Adjuvanted (2023-2024 Formula) (NVX-CoV2601) had received Emergency Use…
Nobel Prize in medicine was jointly awarded to Katalin Kariko and Drew Weissman “for their discoveries concerning nucleoside base modifications that enabled the development of effective mRNA vaccines against COVID-19”
On Oct. 2, 2023, the Nobel Prize in Physiology or medicine was awarded jointly to Katalin Kariko and…
WHO recommended R21/Matrix-M vaccine for malaria prevention
On Oct. 2, 2023, the World Health Organization (WHO) announced it had recommended a new vaccine, R21/Matrix-M, developed…
Pfizer and BioNTech received Health Canada authorization for XBB.1.5-adapted monovalent COVID-19 vaccine
On Sept. 28, 2023, Pfizer and BioNTech that Health Canada had authorized the companies’ Omicron XBB.1.5-adapted monovalent COVID-19…
SARS-CoV-2 infects coronary arteries, increases plaque inflammation
On Sept. 28, 2023, the National Institute of health announced SARS-CoV-2, the virus that causes COVID-19, can directly…
New cancer diagnoses fell abruptly early in the COVID-19 pandemic according to Annual Report to the Nation
On Sept. 27, 2023, the U.S. Centers for Disease Control and Prevention (CDC) reported that new diagnoses of…
Gritstone Bio awarded $433 Mmillion BARDA contract to conduct comparative phase 2b study evaluating next-generation vaccine candidate for COVID-19
On Sept. 27, 2023, Gritstone bio announced that it was awarded a contract by the Biomedical Advanced Research…
Moderna received U.S. FDA approval for updated COVID-19 vaccine
On Sept. 11, 2023, Moderna announced the U.S. Food and Drug Administration (FDA) had approved the supplemental Biologics…
Pfizer and BioNTech received U.S. FDA approval for 2023-2024 COVID-19 vaccine
On Sept. 11, 2023, Pfizer and BioNTech announced that the U.S. Food and Drug Administration (FDA) approved the…
Biotechnology | COVID-19 | FDA | Life Science News | Vaccine
Moderna clinical trial data confirmed updated Covid-19 vaccine generated strong immune response against BA.2.86 variant
On Sept. 6, 2023, Moderna announced that clinical trial data from its research assay confirmed its updated COVID-19…
Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron XBB.1.5-adapted COVID-19 Vaccine in the European Union
On Aug. 30, 2023, Pfizer and BioNTech announced that the Committee for Medicinal Products for Human Use (CHMP)…
WHO initiative signed new licensing agreements on COVID-19 technologies
On Aug. 29, 2023, the COVID-19 Technology Access Pool (C-TAP), a multi-stakeholder partnership to facilitate sharing of intellectual…
CDC reported risk assessment summary for SARS CoV-2 sublineage BA.2.86
On Aug. 23, 2023, the CDC announced it had detected a new SARS-CoV-2 variant labeled BA.2.86. CDC was…
Project NextGen awarded over $1.4 billion to develop future of COVID-19 vaccines and therapeutics
On Aug. 22, 2023, the U.S. Department of Health and Human Services (HHS) announced it had awarded more…
COVID-19 vaccination and boosting during pregnancy benefits pregnant women and newborns
On Aug. 11, 2023, a study funded by the National Institute of Allergy and Infectious Diseases (NIAID) reported…
WHO issued standing recommendations for COVID including Omicron EG.5 variant risk
On Aug. 9, 2023, the World Health Organization (WHO) released standing recommendations for battling COVID-19 and released an…
Scientists developed breath test that rapidly detects COVID-19 virus
On Jul. 31, 2023, scientists at Washington University in St. Louis have developed a breath test that quickly…
JAMA reported excess death rates for Republican and Democratic voters in Florida and Ohio during COVID-19 pandemic
On Jul. 24, 2023, the Journal JAMA reported there is evidence that Republican-leaning counties had higher COVID-19 death…
U.S. FDA approved Vekluryﾮ (Remdesivir) for COVID-19 treatment in patients with Severe renal impairment
On Jul. 14, 2023, Gilead Sciences announced that the U.S. Food and Drug Administration (FDA) had approved a…
CDC launched ﾓBridge Access Programﾔ to provide free COVID-19 vaccines to uninsured and underinsured adults
On Jul. 13, 2023, the Centers for Disease Control and Prevention (CDC) announced the launch of the Bridge…
U.S. FDA updated COVID-19 vaccines for use in the U.S. beginning in Fall 2023
On Jun. 16, 2023, the U.S. Food and Drug Administration’s (FDA) Vaccines and Related Biological Products Advisory Committee…
U.S. FDA permitted marketing of first COVID-19 at-home test using traditional premarket review process
On Jun. 6, 2023, the U.S. FDA granted granted marketing authorization for the Cue COVID-19 Molecular Test. The…
WHO announced simple, easy-to-say labels for SARS-CoV-2 Variants of Interest and Concern
On May 31, 2023, the World Health Organization announced it had assigned simple, easy to say and remember…
Novavax’s Nuvaxovid received positive CHMP opinion for full marketing authorization for prevention of COVID in the EU
On May 26, 2023, Novavax announced that Nuvaxovid (NVX-CoV2373) had been recommended for full Marketing Authorization (MA) for…
U.S. FDA approved Paxlovid, first oral antiviral for treatment of COVID-19 in adults
On May 25, 2023, the U.S. Food and Drug Administration (FDA) approved the oral antiviral Paxlovid (nirmatrelvir tablets…
Large study provided scientists with deeper insight into long COVID symptoms
On May 25, 2023, the National Institutes of Health announced Initial findings from a study of nearly 10,000…
Study found COVID-19 mRNA booster vaccinations in early pregnancy did not increase miscarriage risk
On May 19, 2023, HealthPartners Institute researchers have published new data in JAMA Network Open that shows monovalent…
Obstructive sleep apnea associated with increased risks for long COVID
On May 11, 2023, a National Institutes of Health supported long-term study reported that among people who have…
U.S. Department of Health and Human Services ended the COVID-19 Public Health Emergency
On May 11, 2023, the U.S. Departments of Health and Human Services announced an end of the COVID-19…